SynthesisJournal of orthopaedic surgery and research2020
The worldwide prevalence of the Dupuytren disease: a comprehensive systematic review and meta-analysis.
Synthesis in Journal of orthopaedic surgery and research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 1 synthesis or guideline pooled it, 70 citations in OpenAlex.
- Surgical Management of Dupuytren Disease: A Systematic Review and Network Meta-analyses.Hand (New York, N.Y.) · 2024Pooled it
- Dupuytren Disease Surgical Treatment: A Randomized Clinical Trial Comparing Partial Fasciectomy by Bruner Approach Versus Zetaplasty.Hand (New York, N.Y.) · 2024Trial
- Treatment Injuries in Dupuytren Contracture: A Population-Based Study of Filed Compensation Claims.Journal of hand surgery global online · 2027Article
- The Impact of Emerging Therapies and Declining Physician Reimbursement on Dupuytren Disease Treatment: A 21 Year Review.Journal of hand surgery global online · 2026Article
- Review
- Trends in Treatment and Reimbursement of Dupuytren Disease.Journal of hand surgery global online · 2026Article
- Article
- Likelihood of Dupuytren Contracture Recurrence After Limited Fasciectomy, Needle Aponeurotomy or CollagenaseJournal of hand surgery global online · 2026Article
- Uncoupling TGFβ1 signalling from collagen protein synthesis in Dupuytren's disease.The Journal of pathology · 2026Article
- Treatment of Dupuytren Contracture Recurrence After Surgery With Collagenase Clostridium Histolyticum: A Retrospective Multicenter Series.Journal of hand surgery global online · 2026Article
- Development of a 3D In Vitro Model of Dupuytren's Disease as a Platform for Drug Screening.Cellular and molecular bioengineering · 2026Article
- Associations of Demographic, Lifestyle, and Clinical Factors With the Presence of Dupuytren Disease: Results from the Lifelines Cohort Study.Journal of hand surgery global online · 2025Article
- Determining Risk Factors and Rate of Surgery After Collagenase Injections for Dupuytren Contracture.Journal of hand surgery global online · 2025Article
- Surgical and Injection Interventions for Dupuytren's Disease: A Systematic Review Protocol.Revista brasileira de ortopedia · 2025Article
- [Surgical and Injection Interventions for Dupuytren's Disease: A Systematic Review Protocol].Revista brasileira de ortopedia · 2025Article
- The incidence and prevalence of Dupuytren's disease in primary care: results from a text mining approach on registration data.Scandinavian journal of primary health care · 2025Article
- Celiac Disease and Incident Dupuytren's Contracture: A Matched Nationwide Cohort Analysis.Clinical epidemiology · 2025Article
- [Dupuytren's disease : Epidemiology, diagnosis, treatment, outcome].Orthopadie (Heidelberg, Germany) · 2024Article
- Therapy for Dupuytren's Disease: Collagenase Therapy-A Long-Term Follow-Up Study.Life (Basel, Switzerland) · 2024Article
- Epidemiology and Treatment Trends in the Management of Dupuytren's Disease From 2016 to 2022.Cureus · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 5 institutions in 3 countries.
Funding
Abstract
backgroundThe Dupuytren disease is a benign fibroproliferative disorder that leads to the formation of the collagen knots and fibres in the palmar fascia. The previous studies reveal different levels of Dupuytren's prevalence worldwide; hence, this study uses meta-analysis to approximate the prevalence of Dupuytren globally.
methodsIn this study, systematic review and meta-analysis have been conducted on the previous studies focused on the prevalence of the Dupuytren disease. The search keywords were Prevalence, Prevalent, Epidemiology, Dupuytren Contracture, Dupuytren and Incidence. Subsequently, SID, MagIran, ScienceDirect, Embase, Scopus, PubMed and Web of Science databases and Google Scholar search engine were searched without a lower time limit and until June 2020. In order to analyse reliable studies, the stochastic effects model was used and the I
resultsBy evaluating 85 studies (10 in Asia, 56 in Europe, 2 in Africa and 17 studies in America) with a total sample size of 6628506 individuals, the prevalence of Dupuytren disease in the world is found as 8.2% (95% CI 5.7-11.7%). The highest prevalence rate is reported in Africa with 17.2% (95% CI 13-22.3%). According to the subgroup analysis, in terms of underlying diseases, the highest prevalence was obtained in patients with type 1 diabetes with 34.1% (95% CI 25-44.6%). The results of meta-regression revealed a decreasing trend in the prevalence of Dupuytren disease by increasing the sample size and the research year (P < 0.05).
conclusionThe results of this study show that the prevalence of Dupuytren disease is particularly higher in alcoholic patients with diabetes. Therefore, the officials of the World Health Organization should design measures for the prevention and treatment of this disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.